Showing results (1691-1700 of 3,660) with videos related to

Sort By:
Pageof 366
Breast (Edinburgh, Scotland)|March 9, 2024
Patients' and doctors' views and experiences of the patient safety trajectory of breast cancer careClara Forrest, Martin J O'Sullivan, Max Ryan, et al.
Breast (Edinburgh, Scotland)|February 29, 2024
Breast-conserving surgery is not associated with increased local recurrence in patients with early-stage node-negative triple-negative breast cancer treated with neoadjuvant chemotherapyDavid Krug, Valentina Vladimirova, Michael Untch, et al.
Breast (Edinburgh, Scotland)|February 10, 2024
Breast cancer highlights from 2023: Knowledge to guide practice and future researchMaria-Joao Cardoso, Philip Poortmans, Elżbieta Senkus, et al.
Breast (Edinburgh, Scotland)|April 10, 2024
The impact of symptom clusters on endocrine therapy adherence in patients with breast cancerSommer Agnew, Megan Crawford, Iain MacPherson, et al.
Breast (Edinburgh, Scotland)|April 10, 2024
Radiological, pathological and surgical outcomes after neoadjuvant endocrine treatment in patients with ER-positive/HER2-negative breast cancer with a clinical high risk and a low-risk 70-gene signatureJosefien P van Olmen, Chaja F Jacobs, Sanne A L Bartels, et al.
Breast (Edinburgh, Scotland)|May 31, 2024
Managing sexual health challenges in breast cancer survivors: A comprehensive reviewLinda Cucciniello, Federica Miglietta, Valentina Guarneri, et al.
Breast (Edinburgh, Scotland)|May 17, 2024
Diagnostic accuracy of intraoperative methods for margin assessment in breast cancer surgery: A systematic review & meta-analysisGavin P Dowling, Cian M Hehir, Gordon R Daly, et al.
Breast (Edinburgh, Scotland)|June 9, 2024
Capturing longer term surgical outcome measures as part of routine care of breast cancer patientsAstrid E Leusink, Amy R Godden, Nihal Yildirim, et al.
Breast (Edinburgh, Scotland)|April 23, 2024
Metastases of primary mixed no-special type and lobular breast cancer display an exclusive lobular histologyGitte Zels, Karen Van Baelen, Maxim De Schepper, et al.
Breast (Edinburgh, Scotland)|November 9, 2023
Exploring the clinical outcomes and safety profile of inetetamab treatment in metastatic breast cancer patients: A multicenter assessment of a Chinese-origin recombinant Anti-HER2 monoclonal antibodyBinliang Liu, Ning Xie, Can Tian, et al.
Pageof 366